about
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosisBlood biomarkers for amyotrophic lateral sclerosis: myth or reality?Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis.Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.Neuromuscular ultrasound in polyneuropathies and motor neuron disease.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohortLead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.Outcome measures in amyotrophic lateral sclerosis clinical trialsShortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.Small molecules present in the cerebrospinal fluid metabolome influence superoxide dismutase 1 aggregationSera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols.Increased levels of MIP-1α in CSF and serum of ALS.Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models.Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis
P2860
Q26783410-BC4FBF55-3DF7-415F-9FF4-C004C0269AF8Q33767845-2609C9A6-BCAF-4D43-9712-F8FF89707623Q34276055-77672F86-3061-48B3-BCD9-5BA9751FC4EDQ36014767-16E66634-71E8-446E-ADFC-88CBAEB7CAB1Q36318169-6988FE4F-7656-4AF2-AC5D-8C8B623D8186Q36414413-598E0916-78B8-4263-807F-7C2B22BF0A63Q37164902-BAF69CBE-29DA-4E83-B61D-46FA1B406A87Q38102947-888C7465-D62D-4FB5-AADA-5E0C4696FD8BQ38232360-E5A7DFD3-C27C-434E-BA9F-79780A9DE222Q38683234-364A8CB1-4600-47EA-9F16-46F8791F8BCAQ40380404-0279476C-F2A6-411B-9E8A-4F5EDCF10B10Q41837997-030AA054-BC67-4B80-A748-5D54F3137E49Q42369773-CEBC8C08-52F5-41EF-BCE3-BC5C1EA20FB2Q42664185-5E5404C3-3213-40A5-BE68-B642362C42D5Q44538560-05E9FB35-B86B-4C4F-8868-B9C1BA258F86Q48254168-D1ABAEA7-DB12-4AE7-BB2C-9B78870134FEQ49365640-3B214ABE-9C83-4D44-8A11-5CBDF8ED223EQ53325097-1A89EA65-F5DE-4588-B6EB-1C1E1F73A2C6Q55412795-4DDFF6FA-B99E-4597-B185-9BD02617F150Q58181716-EBE5E600-F7DF-4962-B653-DE479C61EDCB
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CSF markers in amyotrophic lateral sclerosis.
@en
type
label
CSF markers in amyotrophic lateral sclerosis.
@en
prefLabel
CSF markers in amyotrophic lateral sclerosis.
@en
P2093
P2860
P1476
CSF markers in amyotrophic lateral sclerosis.
@en
P2093
Alina Kułakowska
Joanna Tarasiuk
Piotr Lewczuk
Wiesław Drozdowski
P2860
P2888
P304
P356
10.1007/S00702-012-0806-Y
P577
2012-05-04T00:00:00Z